INVIVO THERAPEUTICS
InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in individuals paralyzed as a result of traumatic spinal cord injury. The company was founded in 2005 on the basis of research initiated in the laboratories of Robert Langer, PhD, of the Massachusetts Institute of Technology, Jay Vacanti, MD, of the Massachusetts General and Children’s Hospitals in Boston, and Yang Teng, PhD, MD, of Harvard's Brigham and Women's Hospital.
INVIVO THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2005-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.invivotherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+116178635535
Email Addresses:
[email protected]
Total Funding:
116.24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Arch Therapeutics
Arch Therapeutics is a medical device company offering an innovative therapeutic approach to stasis and barrier applications.
Asthmatx
Asthmatx is a medical device company focused on developing and commercializing a therapeutic treatment for asthma in the United States.
Avanir Pharmaceuticals
Avanir Pharmaceuticals is a biopharmaceutical company focused on providing medicines to patients with central nervous system disorders.
BAROnova
BAROnova is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.
Biosency
BIOSENCY is a medical device company focused on developing smart healthcare solutions.
Brainsgate
BrainsGate is a medical device company developing innovative therapies for patients suffering from central nervous system diseases.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
ConverGene
ConverGene is a small molecule discovery company leveraging rational drug design.
Cryosa
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.
Denali Medical
Denali Medical II is a medical device incubator focused on creating new therapies for unmet and/or underserved clinical needs.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Dynocardia
Dynocardia is a medical device company that offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable.
Echo Therapeutics
Echo Therapeutics develops the Symphony tCGM System, a novel, non-invasive (needle-free) glucose monitoring system for diabetes patients.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Goldfinch Biopharma
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.
MedNews
MedNews is a medical device company developing treatments for patients with heart failure.
MELA Sciences
MELA Sciences is a medical device company focused on the design, development and commercialization of non-invasive tools to provide
Micell Technologies
Micell Technologies is a biomedical device company developing interventional cardiology systems for vascular drug delivery.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Mirabilis Medical
Mirabilis Medical is a medical device company that focuses on the treatment of uterine fibroids that is a common problem for women.
Myomo
Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.
Noctrix Health
Noctrix Health is an early-stage medical device company that focuses on developing a revolutionary therapy for a chronic illness.
Osseon Therapeutics
Osseon Therapeutics develops medical devices for minimally-invasive treatments of degenerative bone and joint diseases.
Paragonix Technologies
Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.
Pearltec AG
Pearltec is a technology company focused on placement, positioning, and fixation solutions for patients in research imaging studies.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Precision Light
Precision Light is operates as a medical device company focused on developing breast, facial.
Pression
Medical device company improving blood flow volume body-wide using smart compression with initial focus on heart failure patients.
Q30 Innovations
Q30 Innovations is a research and development company dedicated to developing innovative products intended to reduce traumatic brain injury.
Recros Medica
Recros Medica is a medical device company developing technologies to treat skin laxity and focal aesthetic contour deformities.
Refocus Group
Refocus Group is a medical device company engaged in the research and development of treatments for human vision disorders.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Synergy Biomedical
Synergy Biomedical is a medical device company that focuses on bringing innovative biomaterial-based products to the orthopedic market.
Thermogenesis
Thermogenesis, a health care company, focuses in development of automated technologies for cell-based therapeutics and bioprocessing.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - InVivo Therapeutics
SternAegis
SternAegis investment in Post-IPO Equity - InVivo Therapeutics
Montrose Capital Partners
Montrose Capital Partners investment in Post-IPO Equity - InVivo Therapeutics
Spencer Trask & Co
Spencer Trask & Co investment in Post-IPO Equity - InVivo Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-13 | InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel |
Official Site Inspections
http://www.invivotherapeutics.com Semrush global rank: 9.96 M Semrush visits lastest month: 73
- Host name: 208.91.197.44
- IP address: 208.91.197.44
- Location: British Virgin Islands
- Latitude: 18.5
- Longitude: -64.5
- Timezone: America/Tortola
More informations about "InVivo Therapeutics"
InVivo Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +116178635535 InVivo Therapeutics Corporation is a medical device company focused on utilizing polymers as a platform technology to develop treatments to restore function in …See details»
Company Description - Stock Analysis
Jul 15, 2024 InVivo Therapeutics Holdings Corp. operates as a research and clinical-stage biomaterials and biotechnology company in the United States. The company engages in …See details»
InVivo Therapeutics - LinkedIn
InVivo Therapeutics | 2,516 followers on LinkedIn. About InVivo Therapeutics InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with …See details»
CureCast Epsiode 48: Dr. Richard Toselli - InVivo Therapeutics
Dec 18, 2020 Unite 2 Fight Paralysis Non Discriminatory Policy. It is our policy to provide equal employment opportunity and prohibit discrimination of all qualified employees and applicants …See details»
InVivo Therapeutics - PitchBook
InVivo Therapeutics General Information Description. InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the …See details»
InVivo Therapeutics - Craft
Apr 15, 2024 InVivo Therapeutics has 5 employees at their 1 location. See insights on InVivo Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
InVivo Therapeutics Holdings Co (NVIVQ) - Stock Analysis
Jul 15, 2024 InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury. CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics …See details»
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE …
Mar 9, 2023 InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatmentSee details»
InVivo Therapeutics Announces Closing of $9 Million Registered …
Oct 11, 2022 InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatmentSee details»
InVivo Therapeutics CEO and Key Executive Team | Craft.co
InVivo Therapeutics's Chief Financial Officer is Richard Christopher. Other executives include Heather Hamel, Chief Legal Officer, General Counsel; William D'Agostino, SVP Operations …See details»
InVivo Therapeutics | Cambridge MA - Facebook
InVivo Therapeutics, Cambridge, Massachusetts. 11,316 likes · 6 were here. InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company with a focus on …See details»
InVivo Therapeutics Receives Investigational Testing Authorization …
Jul 13, 2016 CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today announced that Health Canada has approved the company’s Investigational …See details»
Industry Innovator: InVivo Therapeutics is Reversing a Life Sentence
Sep 10, 2015 InVivo Therapeutics may not have any FDA approvals yet, but the company is already changing lives with their Neuro-Spinal Scaffold (NSS) treatment.. Reversing a Life …See details»
InVivo Therapeutics Announces $9 Million Registered Direct and …
Oct 7, 2022 InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatmentSee details»
InVivo Therapeutics Announces FDA Acceptance of Preclinical …
Jul 13, 2021 InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatmentSee details»
Rapid intervention—pioneering technology: redefining spinal cord …
Www.invivotherapeutics.com Rapid intervention—pioneering technology: redefining spinal cord injury treatment InVivo Therapeutics is developing a resorbable biomaterial scaffold, the …See details»
InVivo Therapeutics : Announces FDA Acceptance of a Modular …
Mar 1, 2016 InVivo Therapeutics Holdings Corp. (NVIV) today announced that the U.S. Food and Drug Administration (FDA) has accepted its proposed Humanitarian Device Exemption …See details»
InVivo Therapeutics Announces 75% Target Enrollment Achieved …
Sep 8, 2021 InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV), a research and clinical-stage biomaterials and biotechnology company with a focus on the treatmentSee details»
NVIVQ InVivo Therapeutics Holdings Corp. - Seeking Alpha
Jul 15, 2024 A high-level overview of InVivo Therapeutics Holdings Corp. (NVIVQ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …See details»
InVivo Therapeutics Announces Publication of 12- and 24-month …
Jun 8, 2022 CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the publication of a peer-reviewed manuscript in …See details»